Primary central nervous system lymphoma (PCNSL) is an aggressive extranodal non-Hodgkin lymphoma confined to the central nervous system and is most commonly associated with immunosuppression, although it may also occur in immunocompetent individuals.We report a case of a 51-yearold immunocompetent female who presented with a two-week history of slurred speech and right-sided facial weakness, initially managed as Bell's palsy.Neuroimaging revealed a solitary left parietal lesion.She underwent craniotomy, and histopathological examination confirmed high-grade B-cell lymphoma.The postoperative course was complicated within 24 hours by intracranial haemorrhage requiring re-exploration, followed by multifocal ischaemic infarcts.Subsequently, she received high-dose methotrexate-based chemotherapy with rituximab, followed by wholebrain radiotherapy.Over the ensuing months, the patient demonstrated gradual neurological improvement with rehabilitation.At five-year follow-up, she remains in remission with stable neurological status.This case highlights the occurrence of PCNSL in an immunocompetent patient, the potential for severe treatment-related complications, and the possibility of meaningful neurological recovery following sequential oncologic and haemorrhagic brain injury.
No takes yet. Share an insight, caveat, or question.
Saeed et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: